ArticleOncotarget2017
Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.
José Luis Ordóñez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleOncotarget2017
José Luis Ordóñez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.